Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraindividual cross-over comparison of Gadobutrol and Gadoterate in DSC-MR perfusion and MR angiography
DRKS00009914Phase 4Completed
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Jan 2016
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gadobutrol and gadoterate meglumine in cerebrovascular disease, ischemic stroke, intracranial stenosis and 1 more (2 arms), sponsored by Universitätsklinikum Erlangen. Started Jan 2016; status: completed.
02
Drugs
gadobutrolgadoterate meglumine
03
Conditions
cerebrovascular diseaseischemic strokeintracranial stenosisinternal carotid artery atherosclerosis (ICAS)
Beyond the preview
Go deeper on DRKS00009914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00009914.